Archive | Longevity Health RSS feed for this section

Congratulations to the LHI Innovator’s Pitch Challenge Winners!

25 Mar

By Jessica Yang, Senior Research Analyst, Asia Business Development, LSN

Life Science Nation (LSN)’s 2-day Longevity, Health & Innovation (LHI) digital partnering conference took place March 18-19. We are very excited to announce the Top Winners of each Innovator’s Pitch Challenge (IPC) session. As the popularity grows for LHI IPC, we had three sessions featuring Therapeutics, Medical Devices & Diagnostics, and Digital Health companies. Attendees voted for their favorite companies based on materials available on the companies’ dedicated webpages, as well as their live pitch and Q&A.

Thank you to each IPC company for participating and sharing your technology and story with the LHI community. Congratulations to the winners, and thanks to all for voting!

Session 1 (Therapeutics) Tied Winners

APIE-Therapeutics, Inc is a preclinical stage biopharmaceutical company pioneering the endothelium vascular niche repair and regeneration platform. By harnessing activation of the Apelin-APJ receptor, we intend to improve patients’ lives suffering from chronic diseases such as Idiopathic Pulmonary Fibrosis (IPF), KidneyMembranous Glomerulonephritis (MGN) & Chronic Kidney Disease (CKD), Scleroderma (SSc) and others.

Panaceutics Rx uses its patented technologies to enable easy access to affordable personalized medicine and wellness, offering unique combination forms to improve adherence, delivered direct to patients. Our mission is to enable personalized combination products for prevention and chronic therapy, with aids to formulation based on an individual’s digital health profile. Individualized, optimized combinations are enabled to be made on-demand using our robotic platforms and patented processes. Under 503A regulatory rules, Panaceutics automates the compounding of individualized therapies to match physician’s prescriptions. We deliver individualized combination therapies in consumer-friendly forms that promote adherence.

Session 2 (Digital Health) Winner

LifeBio is an age-tech company that captures individuals’ life stories and increases social connectedness— to enhance mental health and to improve Alzheimer’s care.

Session 3 (Medical Devices & Diagnostics) Winner

Eye movements offer a window into brain health. neuroFit licensed a NASA-developed oculometric technology co-invented by one of our founders that delivers eye-movement-based metrics, some well-known from physiology (e.g., latency, acceleration, gain) and other more modern sensorimotor metrics (e.g., direction noise, speed tuning) distilled into a summary metric, nFit. Compared to biomarkers from imaging and EEG, oculometric approaches require only a visual display and a well-designed tracking system to yield noninvasive, low-cost biomarkers that can be scaled on consumer devices.

If you’re interested in the next upcoming Innovator’s Pitch Challenge, you can apply for the Digital RESI IPC taking place June 8-10. Applications close May 14!

This image has an empty alt attribute; its file name is digital-june-2021-banner-1100.png

Keep the Conversations Going

18 Mar

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week is off to the races! Digital RESI March has wrapped up with 1,000+ meetings in 3 days and leads into a triple-threat partnering experience consisting of 4D Meets AI, Access China Spring Forum (free), and Longevity, Health & Innovation taking place consecutively March 18-19.

It’s not too late to sign up and get involved in any of these three events! To learn more, visit the Healthtech Partnering Week website. Each conference offers unique opportunities suited for specific technology assets and market solutions. We hope you’ll join us and round out your RESI partnering with the full Healthtech Partnering Week experience!





Introducing Healthtech Partnering Week Innovator’s Pitch Challenge Finalists

11 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN) is pleased to announce next week’s Healthtech Partnering Week (HPW) Innovator’s Pitch Challenge finalists. The Innovator’s Pitch Challenge is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.

Pitching opportunities at LSN partnering events are popular events for startups and investors alike. They provide exposure and experience to the companies, while providing investors with insight into the latest technology organized by sector and interest. Check out our finalists and select a logo to learn more about their participation. Registration is still open, so don’t miss out and sign up today!

Innovator’s Pitch Challenge Finalists

 

Announcing McDermott Will & Emery HPW Workshops

11 Mar

By Gregory Mannix, Vice President International Business Development, LSN

Life Science Nation (LSN) is thrilled to welcome McDermott Will & Emery as Title Sponsor of Healthtech Partnering Week (HPW) with two live workshops accessible to registered attendees of Redefining Early Stage Investments (RESI) and 4D Meets AI.

McDermott Will & Emery has brought valuable insights to LSN’s community of early-stage fundraising companies, investors, service providers, and strategic partnerships for years, and we look forward to bringing their content to the digital stage next week. There’s still time to register for HPW – Sign up for access to McDermott Will & Emery workshops and more!

Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Live Workshop! March 16 | 1 PM EDT (Register for RESI Access)

Instructors:

  • Nancy Briefs, President & CEO, AltrixBio, Inc.
  • David Hendren, Managing Director, Augmentum Ventures
  • Mark Mihanovic, Partner, McDermott Will & Emery
  • Aroma Sharma, Partner, McDermott Will & Emery

This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion. Learn more!

How to Go to Market: Commercializing AI-Based Health Technologies
Live Workshop! March 19 | 10 AM EDT (Register for 4D Meets AI Access)

Instructors:

  • Richie Bavasso, MBA, Co-Founder & CEO, nQ Medical Inc.
  • Carolyn Metnick, JD, Partner, McDermott Will & Emery
  • Michael Ryan, JD, Partner, McDermott Will & Emery
  • Dale Van Demark, JD, Partner, McDermott Will & Emery

This workshop, hosted by our Title Sponsor McDermott Will & Emery, will focus on the various options for and the legal considerations involved with commercializing AI-based healthcare technologies, including regulatory and data strategies. Learn about the range of options, from R&D use to consumer products, from leading members of McDermott’s digital health practice and companies that have blazed the trail. Learn more!

Got a Moment for a Great Match?

4 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireHealthtech Partnering Week (HPW) launches in just over a week, and the team at Life Science Nation (LSN) is proud to welcome 400+ investors to our digital platform to source portfolio assets across life science and healthcare. LSN works with exceptional early-stage companies to connect them with investors and strategic partners that are a fit for their product and stage of development, and one of the most powerful ways that is done is through digital partnering events where attendees can filter through hundreds of opportunities and find the best fits for their needs.

Check out our current list of confirmed investors and sign up to begin booking meetings and making deals!

Confirmed Digital RESI March Investors and Strategic Partners

Confirmed RESI Investors Confirmed 4D Meets AI Investors Confirmed LHI Investors

McDermott Will & Emery joins HPW as Title Sponsor

4 Mar

By Gregory Mannix, Vice President International Business Development, LSN

Life Science Nation (LSN) is joining forces with McDermott Will & Emery to bring insight and education to the community of investors, service providers, and early-stage companies at Healthtech Partnering Week (HPW). HPW features McDermott Will & Emery at Redefining Early Stage Investments (RESI), March 15-17 and 4D Meets AI, March 18-19.

At RESI, the MWE team will showcase their insights and expertise working with successful organizations to achieve their goals for over eighty-five years. The firm will host a workshop on the all-important topic of Negotiating Term Sheets. This interactive workshop will provide wisdom to early stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion.

Partner Brian Malkin, JD will also moderate 4D Meets AI’s Drugs panel discussing the importance of early-stage partnerships in therapeutics and highlighting investors speaking with their portfolio companies on the secrets to their successful partnerships

Sign up for HPW to get to know the MWE team and learn how their team is partnering with entrepreneurs to move their companies forward. Attendees for both RESI and 4D Meets AI can save on bundle pricing – Click here to learn more!

Get involved with sponsorship at Healthtech Partnering Week

Healthtech Partnering Week: Meet the Panelists!

25 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week (HPW) launches in a few weeks and we want to highlight our esteemed panel faculty coming together to share the latest insights in early-stage life science and healthcare. Each panel is structured to tackle a variety of concerns relevant to fundraising executives that are timely and relevant to each major sector, and even specific indications.

Click the panelist photo below to learn more about their panel participation and to sign up for HPW!


Sascha Berger
TVM Capital Life Science

Jean Anne Booth
UnaliWear Inc.

Nat Brinn
VC23

Ivan Burkov
INKEF Capital

Barbara Clarke
The Impact Sea

Evan Cohen
Healthbox

Michele Colucci
DigitalDx Ventures

Marina Cortes
Hike Ventures LLC

Terence Craig
The Impact Seat

Ruchi Dana
DANA Group of Companies

Anne DeGheest
HealthTech Capital

Bettina Ernst
BERNINA BioInvest

Howard Fillit
Alzheimers Drug Discovery Foundation

Mary Furlong
Mary Furlong & Associates

Robert Garber
7wire Ventures

Amit Garg
Tau Ventures

Scott Gazelle
GreyBird Ventures

Tom Gibbs
Debiopharm Innovation Fund

Sam Goldberger
Ambit Health Ventures

Mark Gray
Constant Companion

Chris Haskell
Bayer

Katherine Hill Ritchie
Nottingham Spirk Family Office

Richard Hughen
Linshom

Alicia Irurzun-Lafitte
UCB Ventures

Stephen Johnston
Aging2.0

Kobus Jooste
Syllable

Arnd Kaltofen
VI Partners

Justin Kelly
AXA Venture Partners

Chris Kent
ODS Medical Inc.

Oliver Keown
Intuitive Surgical

Lily Kim
OS Fund

Kristin King
Boston Harbor Angels

Richard Kivel
GrayBella Capital

Daniella Kranjac
Dynamk Capital

David Lapointe
Optina Diagnostics

Thierry Laugel
Kurma Partners

Taja Lester
Health Equity Capital

George Li
Proxima Ventures

Lisa Mendoza
Bayer

Andy Merken
Burns & Levinson

Junaid Mian
SP8CEVC

Neal Mody
Zoic Capital

Richard Morphy
Parkinson's UK

Richard Mulry
Northwell Ventures

Jonathan Ng
Iterative Scopes

Laurie Orlov
Aging and Health Technology

Martin Pfister
High-Tech Gründerfonds

Stephen Pitt
Johnson & Johnson Innovation

Varun Ramdevan
Johnson & Johnson Innovation

Meghana Rao
Johnson & Johnson Innovation

David Rhew
Microsoft

João Ribas
Novo Holdings A/S

Jeffrey Ries
Healthbox

Christopher Rowan
Cove Fund

Florence Rozen
Fonds de solidarité FTQ

Kerry Rupp
True Wealth Ventures

Chirag Shah
Define Ventures

Todd Smith
OdessaConnect

Sherri Snelling
Caregiving Club

Patrik Sobocki
Industrifonden

Catello Somma
TVM Capital Life Science

Weiyong Sun
Daiichi Sankyo

Hung-Loi (Lloyd) Tran
Transpacific Venture Capital Partners

Rick Voight
Vivid-Pi

Tad Weems
Agilent Technologies

Mishael Zohar
OrbiMed Advisors LLC

Khat Zorig
Innospark Ventures

Meghan Zubradt
Johnson & Johnson Innovation

<span>%d</span> bloggers like this: